‡a
Author's 1q21 Gain Combined with High-Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China
‡a
Author's Gain of 1q21 is an adverse prognostic factor for multiple myeloma patients treated by autologous stem cell transplantation: A multicenter study in China
‡a
1q21gaincombinedwithhighriskfactorsisaheterogeneousprognosticfactorinnewlydiagnosedmultiplemyelomaamulticenterstudyinchina
‡A
1q21 Gain Combined with High-Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China
‡9
1
‡a
earlymonoclonalproteindeclinepatternisanindependentprognosticfactorinpatientswithmultiplemyeloma
‡A
Early monoclonal protein decline pattern is an independent prognostic factor in patients with multiple myeloma
‡9
1
‡a
gainof1q21isanadverseprognosticfactorformultiplemyelomapatientstreatedbyautologousstemcelltransplantationamulticenterstudyinchina
‡A
Gain of 1q21 is an adverse prognostic factor for multiple myeloma patients treated by autologous stem cell transplantation: A multicenter study in China
‡9
1
‡a
healthrelatedqualityoflifeofpatientswithmultiplemyelomaarealworldstudyinchina
‡A
Health-related quality of life of patients with multiple myeloma: A real-world study in China
‡9
1